Veterinarian Approved Content
This content has been prepared by Doç. Dr. Mehmet ÇOLAK based on scientific sources.
Pet Health

Vaccination Protocols in Cats and Dogs: WSAVA Guidelines

Doç. Dr. Mehmet ÇOLAK 24 January 2026 108 views

Evidence-based vaccination guide for cats and dogs covering core and non-core vaccines, maternal antibodies, titers, and risk-based protocols.


Vaccination is the most effective method of protection against preventable infectious diseases in dogs and cats. The vaccination guidelines, regularly updated by the WSAVA (World Small Animal Veterinary Association) Vaccination Guidelines Group, form the foundation of evidence-based veterinary medicine. This article comprehensively covers the core/non-core vaccine classification according to the WSAVA 2024 guidelines, maternal antibody interference, vaccine titration, and risk-based protocols.

WSAVA Principle

"Every animal should be protected with core vaccines, while non-core vaccines should be administered based on individual risk assessment." WSAVA recommends avoiding unnecessary vaccination and utilizing vaccine titration (Day et al., 2024).

1. Core and Non-Core Vaccine Classification

1.1 Definitions

Core Vaccines

Definition: Vaccines that all dogs and cats, regardless of geographic location, should receive throughout their lives.

Rationale: High mortality/morbidity, zoonotic potential, widespread distribution

Non-Core Vaccines

Definition: Vaccines recommended based on geographic region, lifestyle, or individual risk factors.

Rationale: Regional diseases, specific exposure risks

1.2 Vaccine Classification in Dogs

Category Disease Agent DOI*
CORE Distemper Canine Distemper Virus (CDV) ≥3 years
Parvovirus Canine Parvovirus-2 (CPV-2) ≥3 years
Hepatitis (Adenovirus) Canine Adenovirus-2 (CAV-2) ≥3 years
Rabies Rabies virus 1-3 years**
NON-CORE Leptospirosis Leptospira spp. 1 year
Kennel Cough Bordetella bronchiseptica 1 year
Parainfluenza Canine Parainfluenza Virus 1-3 years
Lyme Disease Borrelia burgdorferi 1 year

*DOI: Duration of Immunity | **Varies by national legislation

1.3 Vaccine Classification in Cats

Category Disease Agent DOI
CORE Panleukopenia Feline Panleukopenia Virus (FPV) ≥3 years
Herpesvirus Feline Herpesvirus-1 (FHV-1) ≥3 years
Calicivirus Feline Calicivirus (FCV) ≥3 years
Rabies Rabies virus 1-3 years
NON-CORE Feline Leukemia Feline Leukemia Virus (FeLV) 1 year
Chlamydiosis Chlamydia felis 1 year
Bordetellosis Bordetella bronchiseptica 1 year

2. Puppy and Kitten Vaccination Protocol

2.1 Maternally Derived Antibody (MDA) Interference

Puppies and kittens acquire passive immunity through their mother's milk (colostrum). These maternally derived antibodies (MDA) can decrease vaccine efficacy by neutralizing vaccine antigens:

MDA Half-Life
  • In dogs: ~10 days (8-14 weeks of protection for CPV)
  • In cats: ~15 days (8-12 weeks of protection for FPV)

Therefore, the final vaccine dose should be administered at 16 weeks of age or older.

2.2 WSAVA Puppy/Kitten Vaccination Schedule

Age Dog Cat
6-8 weeks DHP (1st dose) FVRCP (1st dose)
10-12 weeks DHP (2nd dose) ± Lepto FVRCP (2nd dose) ± FeLV
14-16 weeks DHP (3rd dose) ± Lepto + Rabies FVRCP (3rd dose) ± FeLV + Rabies
≥16 weeks Critical: Final dose must be at 16 weeks or later (MDA interference)
6-12 months (booster) DHP + Rabies FVRCP + Rabies
Critical Warning

If the final vaccine dose is administered before 16 weeks, sufficient immunity might not develop due to MDA interference. This situation is termed the "immunity gap" and leaves the young animal susceptible to infection.

VetKriter Vaccination Schedule Calculator

Create a personalized vaccination schedule based on your pet's birth date. Receive reminders.

Vaccination Schedule Calculator

3. Adult Vaccination Protocol

3.1 Booster Intervals

WSAVA recommends avoiding unnecessary vaccination and utilizing vaccine titration:

Core Vaccines (MLV*)
  • First booster: After 12 months
  • Subsequent boosters: Every 3 years
  • Alternative: Serological titration
Non-Core Vaccines
  • Leptospirosis: Annually
  • Bordetella: Annually (if at risk)
  • FeLV: Annually (outdoor cats)

3.2 Vaccine Titration

Serological titration measures protective antibody levels, preventing unnecessary vaccination:

Disease Protective Titer Test Method
CDV (Distemper) ≥1:16 (VN) or positive (ELISA) VN, ELISA, IFA
CPV (Parvovirus) ≥1:80 (HI) or positive (ELISA) HI, ELISA
CAV (Adenovirus) ≥1:16 (VN) VN
FPV (Panleukopenia) ≥1:40 (HI) HI, ELISA

4. Special Considerations in Turkey

4.1 Rabies Vaccine Requirement

In Turkey, the rabies vaccine is a legal requirement:

  • First vaccine: at 3 months of age
  • Booster: Annually (some vaccines have a 3-year license)
  • Travel: A titer test may be required for entry into EU countries

4.2 Regional Risk Factors

High-Risk Areas
  • Leptospirosis: Humid regions, water sources
  • Leishmaniasis: Aegean and Mediterranean coasts
  • Ehrlichiosis: Tick-endemic regions
Lifestyle Risks
  • Shelter/Boarding: Bordetella, CIRDC
  • Outdoor cats: FeLV, FIV
  • Hunting dogs: Leptospirosis, Lyme

5. Vaccine Side Effects and Contraindications

5.1 Common Side Effects

  • Local: Swelling and pain at the injection site (1-3 days)
  • Systemic: Mild fever, lethargy, anorexia (24-48 hours)
  • Rare: Anaphylaxis (within minutes), autoimmune reactions

5.2 FISS (Feline Injection-Site Sarcoma) in Cats

FISS Risk

Adjuvanted vaccines in cats increase the risk of sarcoma development at the injection site (1:10,000-1:30,000).

Precaution: Non-adjuvanted vaccines should be preferred, and vaccines should be administered to distal extremities (the 3-2-1 rule).

6. Conclusion

Vaccination is the most effective method of protection against preventable diseases in dogs and cats. WSAVA guidelines support evidence-based, individualized vaccination protocols. Core vaccines should be administered to all animals, while non-core vaccines should be planned according to a risk assessment. Vaccine titration is a valuable tool to prevent unnecessary over-vaccination.


References
  1. Day, M. J., et al. (2024). WSAVA guidelines for the vaccination of dogs and cats. Journal of Small Animal Practice, 65(1), 1-35.
  2. Ford, R. B., et al. (2017). 2017 AAHA canine vaccination guidelines. Journal of the American Animal Hospital Association, 53(5), 243-251.
  3. Scherk, M. A., et al. (2013). 2013 AAFP feline vaccination advisory panel report. Journal of Feline Medicine and Surgery, 15(9), 785-808.
  4. Schultz, R. D. (2006). Duration of immunity for canine and feline vaccines: A review. Veterinary Microbiology, 117(1), 75-79.
  5. Tizard, I. R. (2021). Veterinary immunology (10th ed.). Elsevier.
  6. WSAVA. (2024). WSAVA vaccination guidelines. World Small Animal Veterinary Association.
Tags: Aşı WSAVA Core Non-core Titrasyon İmmünoloji Kuduz Parvovirus

This website uses cookies to improve your experience. By using our site, you accept our Cookie Policy.